Illumina Feb 17, 2026 A Look At Illumina (ILMN) Valuation After Profitability Gains And SomaLogic Acquisition Guidance - simplywall.st
Illumina Feb 16, 2026 Decoding early synaptic failure in Alzheimer’s disease through multiomic analysis - Illumina
Illumina Feb 16, 2026 Illumina’s AI-Driven Data Vision Is Expanding — Will Multiomics Integration Unlock a Transformational Edge? - Smartkarma
Illumina Feb 16, 2026 Illumina: Weak Backlog Support and Rising Competitive Pressures Undermine 2026 Outlook, Justifying Sell Rating - TipRanks
Illumina Feb 16, 2026 The future of global food security may depend on quality agrigenomics software - Illumina
Illumina Feb 15, 2026 Illumina Conservation Deal Highlights New Genomics Demand And Valuation Debate - simplywall.st
Illumina Feb 14, 2026 Illumina (NASDAQ:ILMN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
Illumina Feb 13, 2026 From sample to insight: Streamlining analysis with the Illumina 5-base solution - Illumina
Illumina Feb 12, 2026 Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips - Zacks Investment Research
Illumina Feb 12, 2026 Why Illumina (ILMN) Is Down 12.9% After 2026 Outlook And SomaLogic Deal Close - And What's Next - simplywall.st
Illumina Feb 11, 2026 Whole-genome sequencing in the UK and Europe, with Mark Robinson - pharmaphorum